Biology Reference
In-Depth Information
Bailer RT, Holloway A, Sun J, Margolick JB, Martin M, Kostman J, Montaner LJ. 1999. IL-13
and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral sup-
pression and a lack of disease progression. J Immunol 162: 7534±7542.
Blazquez MV, Macho A, Ortiz C, Lucena C, Lopez-Cabrera M, Sanchez-Madrid F, Munoz E.
1999. Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kB activation:
possible correlation with cell surface tat-binding proteins. AIDS Res Hum Retroviruses 15:
1209±1218.
Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. 1996. The lym-
phocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-entry. Nature 382:
829±833.
Bobrow MN, Harris TD, Shaughnessy KJ, Litt GL. 1989. Catalyzed reporter deposition, a novel
method of signal ampli®cation. Application to immunoassays. J Immunol Methods 125: 279±285.
Bobrow MN, Shaughnessy DJ, Litt GL. 1991. Catalyzed reporter deposition, a novel method of signal
ampli®cation. II. Application to membrane immunoassays. J Immunol Methods 137: 103±112.
Borghi P, Fantuzzi L, Varano B, Gessani S, Puddu P, Conti L, Capobianchi MR, Ameglio F,
Belardelli F. 1995. Induction of interleukin-10 by human immunode®ciency virus type 1 and its
gp120 protein in human monocytes/macrophages. J Virol 69: 1284±1287.
Borvak J, Chou C-S, Bell K, Van Dyke G, Zola H, Ramilo O, Vitetta E. 1995. Expression of CD25
de®nes peripheral blood mononuclear cells with productive versus latent HIV infection. J Im-
munol 155: 3196±3204.
Butera ST, Perez VL, Wu B, Nabel GJ, Folks TM. 1991. Oscillation of the human immuno-
de®ciency virus surface receptor is regulated by the state of viral activation in a CD4
cell model
of chronic infection. J Virol 65: 4645±4653.
Butera ST, Roberts BD, Lam L, Hodge T, Folks TM. 1994. Human immunode®ciency virus type 1
RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency.
J Virol 68: 2726±2730.
Cameron PU, Hunter SD, Jolley D, Sonza S, Mijch A, Crowe SM. 1998. Speci®city of binding of
HIV-1 anti-p24 antibodies to CD4
lymphocytes from HIV-infected subjects. Cytometry 33:
83±88.
Chun T, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K,
Margolick J, Quinn TC, Kuo Y, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano R.
1997. Quanti®cation of latent tissue reservoirs and total body viral load in HIV-1 infection.
Nature 387: 183±188.
Clouse KA, Powell D, Washington I, Poli G, Strebel K, Farrar W, Barstad P, Kovacs J, Fauci A,
Folks TM. 1989. Monokine regulation of human immunode®ciency virus-1 expression in a
chronically infected human T cell clone. J Immunol 142: 431±438.
Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. 1998. HIV-1 Nef protein protects
infected primary cells against killing by cytotoxic t lymphocytes. Nature 391: 397±401.
Conti L, Rainaldi G, Matarrese P, Varano B, Rivabene R, Columba S, Sato A, Belardelli F,
Malorni W, Gassani S. 1998. The HIV-1 Vpr protein acts as a negative regulator of apoptosis in
a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J Exp
Med 187: 403±413.
Costigliola P, Tumietto F, Ficchi E, Chiodo F. 1992. Detection of circulating p24 antigen-positive
CD4
cells during HIV infection by ¯ow cytometry. AIDS 6: 1121±1125.
Elbim C, Pillet S, Prevost MH, Preira A, Girard PM, Rogine N, Matusani H, Hakim J, Israel N,
Gourerot-Pocidalo MA. 1999. Redox and activation status of monocytes from human im-
munode®ciency virus-infected patients: relationship with viral load. J Virol 73: 4561±4566.
Emiliano S, Lint CV, Fischle W, Paras P, Ott M, Brady J, Verdin E. 1996. A point mutation in the
HIV-1 Tat responsive element is associated with postintegration latency. Proc Natl Acad Sci
USA 93: 6377±6381.
